Home Other Building Blocks GW 6471

GW 6471

CAS No.:
880635-03-0
Catalog Number:
AG00GX1C
Molecular Formula:
C35H36F3N3O4
Molecular Weight:
619.6732
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$105
- +
5mg
≥98%
1 week
United States
$228
- +
10mg
≥98%
1 week
United States
$325
- +
25mg
≥98%
1 week
United States
$665
- +
50mg
98%
1 week
United States
$1279
- +
100mg
98%
1 week
United States
$2210
- +
Product Description
Catalog Number:
AG00GX1C
Chemical Name:
GW 6471
CAS Number:
880635-03-0
Molecular Formula:
C35H36F3N3O4
Molecular Weight:
619.6732
MDL Number:
MFCD07784503
IUPAC Name:
N-[(2S)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide
InChI:
InChI=1S/C35H36F3N3O4/c1-4-33(43)39-22-29(40-23(2)20-32(42)26-12-14-28(15-13-26)35(36,37)38)21-25-10-16-30(17-11-25)44-19-18-31-24(3)45-34(41-31)27-8-6-5-7-9-27/h5-17,20,29,40H,4,18-19,21-22H2,1-3H3,(H,39,43)/b23-20-/t29-/m0/s1
InChI Key:
TYEFSRMOUXWTDN-DYQICHDWSA-N
SMILES:
CCC(=O)NC[C@H](Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1)N/C(=C\C(=O)c1ccc(cc1)C(F)(F)F)/C
Properties
Complexity:
954  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
1  
Exact Mass:
619.266g/mol
Formal Charge:
0
Heavy Atom Count:
45  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
619.685g/mol
Monoisotopic Mass:
619.266g/mol
Rotatable Bond Count:
14  
Topological Polar Surface Area:
93.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
7.9  
Literature
Title Journal
Activation of peroxisome proliferator-activated receptor α ameliorates perfluorododecanoic acid-induced production of reactive oxygen species in rat liver. Archives of toxicology 20160601
Inhibition of PPARα attenuates vimentin phosphorylation on Ser-83 and collapse of vimentin filaments during exposure of rat Sertoli cells in vitro to DBP. Reproductive toxicology (Elmsford, N.Y.) 20141201
Sargahydroquinoic acid inhibits TNFα-induced AP-1 and NF-κB signaling in HaCaT cells through PPARα activation. Biochemical and biophysical research communications 20140808
Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway. Chemico-biological interactions 20131005
SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging. Biochemical pharmacology 20130501
Pretreatment with proteasome inhibitors protects against oxidative injuries via PPARα-dependent and -independent pathways in ARPE-19 cells. Investigative ophthalmology & visual science 20120831
Alteration of neuropathic and visceral pain in female C57BL/6J mice lacking the PPAR-α gene. Psychopharmacology 20120801
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α. The Journal of biological chemistry 20120720
Effects of palmitoylethanolamide on aqueous humor outflow. Investigative ophthalmology & visual science 20120701
Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration. Pharmacology, biochemistry, and behavior 20120301
OxLDL up-regulates Niemann-Pick type C1 expression through ERK1/2/COX-2/PPARα-signaling pathway in macrophages. Acta biochimica et biophysica Sinica 20120201
Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α. Molecular and cellular endocrinology 20120102
Chemical cross-linking and high-resolution mass spectrometry to study protein-drug interactions. Methods in molecular biology (Clifton, N.J.) 20120101
Fenofibrate down-regulates renal OCT2-mediated organic cation transport via PPARα-independent pathways. Drug metabolism and pharmacokinetics 20120101
The role of PPARα in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia/reperfusion in rats. International journal of molecular sciences 20120101
Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms. European journal of cell biology 20110801
Regulation mechanism of ABCA1 expression by statins in hepatocytes. European journal of pharmacology 20110715
Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. Journal of lipid research 20110501
Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo. Experimental biology and medicine (Maywood, N.J.) 20110101
Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Molecular medicine (Cambridge, Mass.) 20110101
13-hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages. Lipids in health and disease 20110101
Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes. Clinical and experimental pharmacology & physiology 20101101
Adiponectin-mediated heme oxygenase-1 induction protects against iron-induced liver injury via a PPARα dependent mechanism. The American journal of pathology 20101001
Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat. Shock (Augusta, Ga.) 20100801
Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis. Leukemia 20100801
Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. International journal of molecular medicine 20100501
An innovative method to study target protein-drug interactions by mass spectrometry. Journal of medicinal chemistry 20090514
Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain. British journal of pharmacology 20081201
Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20080801
Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. Neuropharmacology 20080701
Time-dependence of cardiomyocyte differentiation disturbed by peroxisome proliferator-activated receptor alpha inhibitor GW6471 in murine embryonic stem cells in vitro. Acta pharmacologica Sinica 20070501
Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. The Journal of biological chemistry 20020719
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 20020214
Properties